PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-07-31 was 413.33K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-10-31 was 90.70K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 440.00K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 413.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-07-31 | 440.00K shares 10-K · filed 2020-10-08 | |
| 2015-07-31 | 413.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-28 | 413.33K shares 10-K · filed 2015-10-28 |
| 2013-10-31 | 90.70K shares 10-Q · filed 2014-12-11 |